Partner Jonathan P. O’Brien, Ph.D. Named LMG Life Sciences 2023 Patent Strategy Attorney of the Year – Midwest

Honigman is pleased to announce that Partner Jonathan P. O’Brien, Ph.D. was recognized by LMG Life Sciences as the 2023 Patent Strategy Attorney of the Year – Midwest.

Jonathan counsels life sciences clients through a wide range of IP related matters. He is currently assisting his clients with the development of nearly a dozen late stage pharmaceutical and biotechnology clinical candidates as potential therapies among a broad range of therapeutic areas, including oncology, cardiology, gastrointestinal and infectious diseases.

LMG Life Sciences is the only legal ranking directory to identify the leading law firms and individuals in each practice area of the life sciences industry. The annual awards event highlights the accomplishments of leading law firms and individuals behind the most innovative and challenging work in the life sciences industry.

In addition to Jonathan’s recognition, Honigman was shortlisted as the Patent Strategy Firm of the Year. Partner Phillip Torrence was shortlisted as a Venture Capital Attorney of the Year and Partner Harold Fox, Ph.D. was shortlisted as a Patent Strategy Attorney of the Year – DC Metro.

About Honigman
Honigman LLP is an Am Law 200 full-service, general business law firm with more than 350 attorneys counseling clients on complex issues across the country in Chicago, Michigan (Ann Arbor, Bloomfield Hills, Detroit, Grand Rapids, Kalamazoo and Lansing), Washington, D.C. and in our newest wholly owned subsidiary office in Israel. Our lawyers counsel clients on complex issues in more than 60 areas of law. For more information visit www.honigman.com.